Polymorphism of MPT64 and PstS1 in Mycobacterium tuberculosis is not likely to affect relative immune reaction in human
- PMID: 31804315
- PMCID: PMC6919535
- DOI: 10.1097/MD.0000000000018073
Polymorphism of MPT64 and PstS1 in Mycobacterium tuberculosis is not likely to affect relative immune reaction in human
Abstract
Background: MPT64 and PstS1 are the earliest known immune-dominant antigens of Mycobacterium tuberculosis and have been commonly used as candidates in the diagnosis of tuberculosis.
Methods: We constructed recombinant plasmids pET-32a-Rv0934 and pET-32a-Rv1980c to express both wild and mutant forms of MPT64 and PstS1 and purified them. From November 9 to December 9, 2016, and November 9 to December 10, 2017, 96 patients with tuberculosis, 53 patients without tuberculosis, and 96 healthy volunteers were enrolled in this study. We used the purified proteins as antigens to perform T-spot and enzyme-linked immunosorbent assay (ELISA) for samples obtained from healthy volunteers and tuberculosis patients.
Results: Regarding T-spot, the area under the curve (AUC) values for MPT64-wild protein (MPT64-H37Rv) and MPT64-mutant protein (MPT64-FJ05395) were 0.723 and 0.750, respectively. The AUC values for PstS1-H37Rv, PstS1-FJ05132, and PstS1-JL06035 were 0.817, 0.796, and 0.745, respectively. With regard to ELISA, the AUC values for MPT64-H37Rv and MPT64-FJ05395 were 0.525 and 0.528, respectively, while those for PstS1-H37Rv, PstS1-FJ05132, PstS1-JL06035 were 0.588, 0.509, and 0.560, respectively. There was no difference between wild and mutant proteins when we used them as antigens to perform T-spot and ELISA assays.
Conclusion: MPT64 and PstS1 are likely candidate diagnostic antigens for M tuberculosis T-spot test, at least in combination with other proteins. Polymorphisms of MPT64 and PstS1 had little effect on cell-mediated and humoral immunity in the host.
Conflict of interest statement
The authors have no conflicts of interest to disclose.
Figures





Similar articles
-
Quantitative detection of a cocktail of mycobacterial MPT64 and PstS1 in tuberculosis patients by real-time immuno-PCR.Future Microbiol. 2019 Feb;14:223-233. doi: 10.2217/fmb-2018-0284. Epub 2019 Jan 21. Future Microbiol. 2019. PMID: 30663893
-
Expression, purification and improved antigenicity of the Mycobacterium tuberculosis PstS1 antigen for serodiagnosis.Protein Expr Purif. 2014 Mar;95:77-83. doi: 10.1016/j.pep.2013.11.011. Epub 2013 Dec 8. Protein Expr Purif. 2014. PMID: 24326191
-
Truncation of PstS1 antigen of Mycobacterium tuberculosis improves diagnostic efficiency.Tuberculosis (Edinb). 2013 Nov;93(6):654-9. doi: 10.1016/j.tube.2013.07.005. Epub 2013 Aug 11. Tuberculosis (Edinb). 2013. PMID: 23978525
-
[Immunoprophylaxis of recombinant Mycobacterium vaccae secreted MPT64 of Mycobacterium tuberculosis].Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2009 Mar;25(3):211-4. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2009. PMID: 19257983 Chinese.
-
[Evolution of IGRA researches].Kekkaku. 2008 Sep;83(9):641-52. Kekkaku. 2008. PMID: 18979999 Review. Japanese.
Cited by
-
Synthesis of plant-based, self-adjuvanted, dual antigen specific to Mycobacterium tuberculosis as a novel tuberculosis subunit vaccine that elicits immunogenicity in rabbit.Biotechnol Lett. 2023 Jun;45(5-6):703-717. doi: 10.1007/s10529-023-03371-1. Epub 2023 Apr 19. Biotechnol Lett. 2023. PMID: 37074553 Free PMC article.
-
MPT64 assays for the rapid detection of Mycobacterium tuberculosis.BMC Infect Dis. 2021 Apr 10;21(1):336. doi: 10.1186/s12879-021-06022-w. BMC Infect Dis. 2021. PMID: 33838648 Free PMC article.
-
Expression and epitope prediction of MPT64 recombinant proteins from clinical isolates of Mycobacterium tuberculosis as immunoserodiagnostic candidates.Vet World. 2022 Oct;15(10):2376-2383. doi: 10.14202/vetworld.2022.2376-2383. Epub 2022 Oct 8. Vet World. 2022. PMID: 36425128 Free PMC article.
-
A novel multi-component protein vaccine ECP001 containing a protein polypeptide antigen nPstS1 riching in T-cell epitopes showed good immunogenicity and protection in mice.Front Immunol. 2023 Apr 21;14:1138818. doi: 10.3389/fimmu.2023.1138818. eCollection 2023. Front Immunol. 2023. PMID: 37153610 Free PMC article.
References
-
- Mustafa AS. HLA-promiscuous Th1-cell reactivity of MPT64 (Rv1980c), a major secreted antigen of Mycobacterium tuberculosis, in healthy subjects. Med Princ Pract 2009;18:385–92. - PubMed
-
- Mustafa AS, Shaban F. Mapping of Th1-cell epitope regions of Mycobacterium tuberculosis protein MPT64 (Rv1980c) using synthetic peptides and T-cell lines from M. tuberculosis-infected healthy humans. Med Princ Pract 2010;19:122–8. - PubMed
-
- Braibant M, Lefevre P, de Wit L, et al. A Mycobacterium tuberculosis gene cluster encoding proteins of a phosphate transporter homologous to the Escherichia coli Pst system. Gene 1996;176:171–6. - PubMed
-
- Vordermeier HM, Coombes AG, Jenkins P, et al. Synthetic delivery system for tuberculosis vaccines: immunological evaluation of the M. tuberculosis 38 kDa protein entrapped in biodegradable PLG microparticles. Vaccine 1995;13:1576–82. - PubMed
-
- Young DB, Garbe TR. Lipoprotein antigens of Mycobacterium tuberculosis. Res Microbiol 1991;142:55–65. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical